Axa’s Intersect ENT, Inc XENT Stock Holding History

Axa’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,176	Closed	-$681K	–	1411
2018 Q2	$681K	Hold	18,176	–	–	﹤0.01%	1090
2018 Q1	$714K	Buy	18,176 +10,400	+134%	+$380K	﹤0.01%	1081
2017 Q4	$252K	Buy	+7,776	New	+$233K	﹤0.01%	1274

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa's XENT Position: Q3 2018 in Review

Axa sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 18,176 shares — an estimated $681K sold.

Axa first reported a position in XENT in Q4 2017 and held it in 3 quarters. The position peaked at $714K in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

Axa reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
Axa sold 18,176 Intersect ENT, Inc shares in Q3 2018, an estimated $681K.
Axa first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 3 quarters.
Axa's Intersect ENT, Inc position peaked at $714K in Q1 2018.
138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.